| 英文别名 |
SP 600125, negative control;AKOS040756318;HMS3229I18;CS-0045451;HY-112402;N1-Methyl-1,9-pyrazoloanthrone;SP 600125, negative control?;14-methyl-14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;54642-23-8;14-methyl-14,15-diazatetracyclo[7.6.1.0(2),?.0(1)(3),(1)?]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;G68745;14-methyl-14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;SDCCGSBI-0086764.P003;DA-74673;SCHEMBL8171875;BDBM50347921;14-Methyl-14,15-diazatetracyclo[7.6.1.02,?.013,1?]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;CHEMBL1802485;JNK Inhibitor II, Negative Control;TS-08892;14-methyl-14,15-diazatetracyclo[7.6.1.0?,?.0??,??]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one;GTPL5999;CCG-206857;JNK inhibitor, negative control;2-methyldibenzo[cd,g]indazol-6(2H)-one |
微信公众号
客服
C)
